• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

ATLN:VX

85.850 CHF 0.150 0.18%

As of 11:43:58 ET on 04/17/2014.

Company Profile for Actelion Ltd (ATLN)

Actelion Ltd. is a pharmaceutical company that develops and markets synthetic small-molecule drugs against diseases related to the endothelium. The Company's drugs, Veletri and Tracleer, are used in the treatment of heart and pulmonary conditions.

Contact Information

Actelion Ltd

Gewerbestrasse 16
Allschwil, 4123
Switzerland
Phone: 41-61-565-65-65
Fax: 41-61-565-65-00

Key Executives for Actelion Ltd (ATLN)

Jean-Paul ClozelCEO/Co-FounderAndre C MullerChief Financial Officer
Otto SchwarzExec VP/COONicholas FrancoVP/Chief Bus Dev Officer
Guy BraunsteinExec VP/Head:Clinical DevMarian BorovskySenior VP/Secy/General Counsel
Martine ClozelSenior VP/Head:Drug/Co-FounderChristian AlbrichSenior VP/Head:Human Resources
Roland HaefeliSenior VP/Head:Investor RelationsPeter HerrmannVP/Head:Corporate Affrs/Compliance
Beat SteinerVP/Head:Drug Discovery BiologyThomas WellerVP/Head:Drug Discovery & Chem

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil